Amgen's Phase III Findings Show Palifermin Effective In Mucositis Dec. 10, 2003 By Aaron Lorenzo No Comments
Amgen's Phase III Findings Show Palifermin Effective In Mucositis Dec. 10, 2003 By Aaron Lorenzo No Comments
Various Phase III Studies Bolster Use Of Rituxan For Treating NHL Dec. 9, 2003 By Aaron Lorenzo No Comments
Various Phase III Studies Bolster Use Of Rituxan For Treating NHL Dec. 9, 2003 By Aaron Lorenzo No Comments
AVI Adds $15M To Balance Sheet Through Direct Equity Placement Dec. 5, 2003 By Aaron Lorenzo No Comments
AVI Adds $15M To Balance Sheet Through Direct Equity Placement Dec. 5, 2003 By Aaron Lorenzo No Comments
Introgen Raises $20 Million To Further Fund Its Cancer Studies Dec. 2, 2003 By Aaron Lorenzo No Comments
Introgen Raises $20 Million To Further Fund Its Cancer Studies Dec. 2, 2003 By Aaron Lorenzo No Comments
Praecis Gets First Approval: Plenaxis In Prostate Cancer Dec. 1, 2003 By Aaron Lorenzo No Comments Prostate cancer patients gained a new treatment option on Nov. 25 as the FDA approved Plenaxis, a drug fully developed by Praecis Pharmaceuticals Inc. (BioWorld Today)Read More
